Profile | GDS5420 / 1558448_a_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 948.14 | 78 |
GSM1296119 | B_lesional_pre-dose | 251.6 | 56 |
GSM1296076 | C_lesional_pre-dose | 145.29 | 49 |
GSM1296092 | D_lesional_pre-dose | 197.41 | 54 |
GSM1296103 | E_lesional_pre-dose | 550.06 | 69 |
GSM1296078 | F_lesional_pre-dose | 111.26 | 44 |
GSM1296107 | G_lesional_pre-dose | 329.72 | 61 |
GSM1296109 | H_lesional_pre-dose | 403.68 | 63 |
GSM1296080 | I_lesional_pre-dose | 600.57 | 71 |
GSM1296090 | J_lesional_pre-dose | 176.64 | 52 |
GSM1296074 | K_lesional_pre-dose | 158.28 | 51 |
GSM1296111 | L_lesional_pre-dose | 215.99 | 53 |
GSM1296099 | M_lesional_pre-dose | 433.64 | 65 |
GSM1296086 | O_lesional_pre-dose | 226.14 | 56 |
GSM1296117 | P_lesional_pre-dose | 246.6 | 55 |
GSM1296113 | Q_lesional_pre-dose | 365.26 | 62 |
GSM1296096 | R_lesional_pre-dose | 381.03 | 63 |
GSM1296105 | S_lesional_pre-dose | 552.9 | 69 |
GSM1296098 | T_lesional_pre-dose | 1074.94 | 80 |
GSM1296101 | U_lesional_pre-dose | 792.01 | 75 |
GSM1296121 | V_lesional_pre-dose | 266.72 | 57 |
GSM1296088 | W_lesional_pre-dose | 345.66 | 62 |
GSM1296082 | X_lesional_pre-dose | 218.25 | 55 |
GSM1296115 | Y_lesional_pre-dose | 277 | 57 |
GSM1296084 | Z_lesional_pre-dose | 567.48 | 70 |
GSM1296072 | B_lesional_day8 | 393.06 | 63 |
GSM1296069 | L_lesional_day8 | 252.95 | 55 |
GSM1296071 | P_lesional_day8 | 362.74 | 61 |
GSM1296070 | Y_lesional_day8 | 351.11 | 61 |
GSM1296073 | V_lesional_day8 | 230.97 | 55 |
GSM1296034 | A_lesional_day15 | 2228.53 | 91 |
GSM1296041 | G_lesional_day15 | 262.48 | 57 |
GSM1296035 | R_lesional_day15 | 540.35 | 69 |
GSM1296038 | U_lesional_day15 | 369.59 | 63 |
GSM1296047 | B_lesional_day15 | 373.67 | 62 |
GSM1296039 | E_lesional_day15 | 315.63 | 60 |
GSM1296042 | H_lesional_day15 | 257.68 | 56 |
GSM1296043 | L_lesional_day15 | 314.72 | 59 |
GSM1296037 | M_lesional_day15 | 958.38 | 79 |
GSM1296046 | P_lesional_day15 | 395.45 | 63 |
GSM1296044 | Q_lesional_day15 | 385.14 | 62 |
GSM1296045 | Y_lesional_day15 | 295.86 | 58 |
GSM1296025 | C_lesional_day15 | 745.17 | 74 |
GSM1296033 | D_lesional_day15 | 340.25 | 61 |
GSM1296027 | I_lesional_day15 | 325.92 | 61 |
GSM1296032 | J_lesional_day15 | 698.13 | 73 |
GSM1296024 | K_lesional_day15 | 807.29 | 76 |
GSM1296031 | W_lesional_day15 | 592.71 | 70 |
GSM1296028 | X_lesional_day15 | 574.51 | 70 |
GSM1296029 | Z_lesional_day15 | 594.46 | 70 |
GSM1296026 | F_lesional_day15 | 289.01 | 59 |
GSM1296030 | O_lesional_day15 | 290.54 | 60 |
GSM1296040 | S_lesional_day15 | 884.2 | 77 |
GSM1296036 | T_lesional_day15 | 1238.16 | 83 |
GSM1296048 | V_lesional_day15 | 269.62 | 57 |
GSM1296059 | A_lesional_day43 | 591.42 | 70 |
GSM1296066 | G_lesional_day43 | 326.99 | 60 |
GSM1296060 | R_lesional_day43 | 444.83 | 66 |
GSM1296063 | U_lesional_day43 | 258.88 | 57 |
GSM1296064 | E_lesional_day43 | 273.22 | 58 |
GSM1296067 | H_lesional_day43 | 470.11 | 66 |
GSM1296062 | M_lesional_day43 | 1004.25 | 79 |
GSM1296068 | Q_lesional_day43 | 334.56 | 60 |
GSM1296050 | C_lesional_day43 | 279.36 | 58 |
GSM1296057 | D_lesional_day43 | 601.19 | 70 |
GSM1296052 | I_lesional_day43 | 421.31 | 65 |
GSM1296054 | J_lesional_day43 | 794.66 | 75 |
GSM1296049 | K_lesional_day43 | 456.15 | 66 |
GSM1296055 | W_lesional_day43 | 312.93 | 59 |
GSM1296053 | X_lesional_day43 | 787.49 | 75 |
GSM1296058 | Z_lesional_day43 | 586.36 | 70 |
GSM1296051 | F_lesional_day43 | 156.48 | 49 |
GSM1296056 | O_lesional_day43 | 362.64 | 63 |
GSM1296065 | S_lesional_day43 | 350.93 | 61 |
GSM1296061 | T_lesional_day43 | 1342.38 | 84 |
GSM1296095 | A_non-lesional_pre-dose | 467.06 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 323.71 | 60 |
GSM1296077 | C_non-lesional_pre-dose | 546.99 | 69 |
GSM1296093 | D_non-lesional_pre-dose | 1429.26 | 85 |
GSM1296104 | E_non-lesional_pre-dose | 335.84 | 61 |
GSM1296079 | F_non-lesional_pre-dose | 338.61 | 62 |
GSM1296108 | G_non-lesional_pre-dose | 351.3 | 61 |
GSM1296110 | H_non-lesional_pre-dose | 403.18 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 1839.7 | 88 |
GSM1296091 | J_non-lesional_pre-dose | 259.39 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 172.93 | 51 |
GSM1296112 | L_non-lesional_pre-dose | 400.93 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 1365.72 | 84 |
GSM1296087 | O_non-lesional_pre-dose | 206.04 | 55 |
GSM1296118 | P_non-lesional_pre-dose | 498 | 67 |
GSM1296114 | Q_non-lesional_pre-dose | 384.33 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 406.6 | 64 |
GSM1296106 | S_non-lesional_pre-dose | 720.06 | 74 |
GSM1296102 | U_non-lesional_pre-dose | 811.53 | 76 |
GSM1296122 | V_non-lesional_pre-dose | 441.7 | 66 |
GSM1296089 | W_non-lesional_pre-dose | 596.81 | 70 |
GSM1296083 | X_non-lesional_pre-dose | 1790.91 | 88 |
GSM1296116 | Y_non-lesional_pre-dose | 367.18 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 563.08 | 69 |